Search Results
Viewing: 1-10 of 11 | All
News
Dr. Jonathan L. Finlay Recipient of The Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer
During the Wyss Family Symposium, hosted by Nationwide Children’s Hospital May 11-12, Jonathan L. Finlay, MB, ChB, FRCP, Director of Neuro-Oncology at Nationwide Children’s, will be announced as the first recipient of The Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer.
News
Jonathan L. Finlay, MB, ChB, FRCP Appointed Director of Neuro-Oncology at Nationwide Childrens Hospital
Jonathan L. Finlay, MB, ChB, FRCP, will begin his appointment as director of Neuro-Oncology at Nationwide Children’s Hospital today. In addition to his appointment at Nationwide Children’s, Dr.

News
Dr. Jonathan Finlay Receives Lifetime Achievement Award from Society for Neuro-Oncology
(COLUMBUS, Ohio) – Jonathan Finlay, MB, ChB, FRCP, program director of Neuro-Oncology at Nationwide Children’s Hospital, has become the first pediatric specialist to receive the Society for Neuro-Oncology’s Lifetime Achievement Award, which may be awarded to anyone connected to
News
Maryam Fouladi, MD, Named Co-Executive Director of Pediatric Neuro-Oncology Program
Dr. Fouladi will continue her extensive work on brain stem gliomas (DIPG) at Nationwide Children’s alongside Jeffrey Leonard, MD, co-executive director of the Pediatric Neuro-Oncology Program and chief of Neurosurgery at Nationwide Children’s.
Article
NEXT Consortium
The NEXT Consortium is a collaborative research model that unites multiple research centers with the goal of expediting the most advanced treatments in the shortest time frame possible in pediatric oncology, hematology and bone marrow transplant.
News
Nationwide Childrens Hospital Receives $5 Million Gift from Worthington Industries and McConnell Family Foundations Establishing the NEXT Consortium
Nationwide Children’s Hospital announced today it has received a combined $5 million gift from Worthington Industries and the McConnell Family Foundation to help establish the National Experimental Therapeutics (NEXT) Consortium.

Article
Head Start 4
The Head Start 4 protocol is a randomized clinical trial hosted and coordinated by Nationwide Children’s NEXT Consortium.
News
MEDIA ADVISORY: Fifth Annual International Central Nervous System Germ Cell Tumor Conference
MEDIA ADVISORY WHAT: Fifth Annual International Central Nervous System Germ Cell Tumor Conference hosted by Nationwide Children’s Hospital. Germ cells are a specific cell that grows during the development of a fetus. These cells go on to become sperm in the testicles or eggs in the ovaries.
Article
Childhood Cancer Awareness Month
Learn how Nationwide Children's Hospital is participating in Childhood Cancer Awareness Month.

Article
Solving Kids' Cancer Podcasts
Listen to Division Chief Dr. Timothy P. Cripe, MD, PhD and his colleagues as they explore various topics about pediatric cancer research through their podcast.